Merck Is Inspiring Innovation Through Diversity and Inclusion
When we bring together people from different backgrounds, the possibilities for invention are endlessNORTHAMPTON, MA / ACCESSWIRE / February 13,...
Disability
New Late Breaking Preliminary Data Demonstrate Balt’s Squid™ Liquid Embolic May Improve Outcomes in Patients with Chronic Subdural Hematomas
BOSTON, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Balt, Inc., a global technology leader in neurovascular devices, today announced the presentation...
Veru Reports Fiscal 2024 First Quarter Financial Highlights
—Company receives FDA IND clearance for the development of enobosarm in combination with GLP-1 drugs for potentially higher quality weight...
One month left to submit a claim under the First Nations Drinking Water Settlement
TORONTO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Eligible First Nations communities and individuals have until March 7, 2024, to submit...
Veru to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
MIAMI, FL, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regions
Magdalena aiming to submit Investigational New Drug application in 2024 to the FDA for this next-generation psychoactive prescription drug candidate...
Alarming Surge in Needlestick Injuries Tackled With Essential Guide to Proper Medical Waste Disposal
BioMedical Waste Solutions Encourages Healthcare Facilities, Professionals and Individuals Utilizing Needles to Read Its Comprehensive Guide for Assistance With the...
Fighting leprosy with artificial intelligence: DAHW and Belle.ai join forces with Senegal’s Ministry of Health and Social Action to detect and combat neglected diseases
WÜRZBURG, Germany and CAMBRIDGE, Mass., Jan. 24, 2024 (GLOBE NEWSWIRE) -- DAHW German Leprosy and Tuberculosis Relief Association and BelleTorus...
CORRECTING and REPLACING Nalu Medical, Inc. Presents Long-term and Holistic Outcomes from the COMFORT RCT for PNS at NANS 2024
CARLSBAD, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The updated release reads: NALU...
Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference
DALLAS, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on...
ACMHCK and KDADS Select Netsmart to Propel Statewide Integration of CCBHCs in Kansas
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#BehavioralHealth--The Association of Community Mental Health Centers of Kansas (ACMHCK) has chosen Netsmart and its industry-leading Population...
Smoking Claims More Than 6,500 Lives, Costs Minnesota Over $9 Billion Annually
New report commissioned by Blue Cross and Blue Shield of Minnesota exposes the ramifications of smoking on health and the...
Introducing Elument: Trailblazing the Future of Mental Health and Wellness
NASHVILLE, TN / ACCESSWIRE / January 16, 2024 / Elument,a trailblazer in mental health & wellness services, is proud to...
Aruna Bio Announces FDA Clearance of IND for Lead Program AB126, Enabling the First Exosome to Enter in Human Clinical Trials for a Neurological Indication
-Phase 1b/2a clinical trial in acute ischemic stroke expected to initiate in 1H 2024- -Marks the first IND for Aruna’s...
Theralase(R) Provides Update on Phase II Bladder Cancer Clinical Study
TORONTO, ON / ACCESSWIRE / January 15, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")...
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital
-- Brooks Rehabilitation Hospital adds a second site to the registrational program in stroke, and brings the total number of...
Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome
Initiation of REVEAL pediatric trial in the U.S. broadens the clinical evaluation of TSHA-102 to female patients 5-8 years old...
BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President
ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss
MIAMI, FL, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio
Positive preliminary analysis of 15 mg cohort in the PRAX-628 study in epilepsy patients with Photo-Paroxysmal Response (PPR) exceeds expectations;...